TIZANIDINE HYDROCHLORIDE
NDC 50742-224, tizanidine hydrochloride, capsule, from Ingenus Pharmaceuticals, LLC.
- Product NDC
- 50742-224
- Status
- Listed
- Labeler
- Ingenus Pharmaceuticals, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210267
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50742-224 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIZANIDINE HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50742-224-15 | 50742022415 | 150 CAPSULE in 1 BOTTLE, PLASTIC (50742-224-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/99cc8f5f-b947-4ddc-99b6-1e4cef09b717NADAC price for package 50742022415
GET /v1/drugs/nadac/50742022415
Use it
Look up 50742-224 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50742-224 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50742-224. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.